(Oncolytic virus)

授权管线 · — · —

授权管线Confidentiality：公开

INN / Generic Name: (Oncolytic virus)
Dosage Form: —
Strength: —
Therapy Area: Oncology
Indication: Head and neck squamous cell carcinoma; Lung cancer; Ovarian cancer; Sarcoma; Triple negative breast cancer
Current Status: 新药候选授权（UB084）· 临床前（Preclinical）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: 授权 / 共同开发（视靶点与阶段）
MOQ: 1 个项目
Lead Time: 询价
Price Range: 询价

Registrable Markets

China

Process / Sequence / Exact Price